Back
ProShares UltraPro Short MidCap400 Vs. Novo Nordisk AS Industry Stock Comparison
Buy
51
SMDD
ProShares UltraPro Short MidCap400
Last Price:
$8.68
Seasonality Move:
-5.48%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.33
Seasonality Move:
6.58%
Buy
51
ProShares UltraPro Short MidCap400 (SMDD)
is a Buy
Is ProShares UltraPro Short MidCap400 a Buy, Sell or Hold?
-
The current ProShares UltraPro Short MidCap400 [SMDD] share price is $9.01. The Score for SMDD is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
SMDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SMDD Stock Price Chart
What is ProShares UltraPro Short MidCap400's stock price today?
-
The ProShares UltraPro Short MidCap400 share price today is $9.01The current trend is moderately bullish and SMDD is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 67.78 | Buy |
Chaikin Money Flow: | -3681 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.26 - 8.44) | Buy |
Bollinger Bands (100): | (7.98 - 10.36) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | 14079249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.16 - 111.42) | Sell |
Bollinger Bands (100): | (106.53 - 131.27) | Sell |
SMDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.34 | Buy |
20-day SMA: | 7.76 | Buy |
50-day SMA: | 8.25 | Buy |
200-day SMA: | 10.13 | Sell |
8-day EMA: | 8.5 | Buy |
20-day EMA: | 8.13 | Buy |
50-day EMA: | 8.34 | Buy |
200-day EMA: | 10.44 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.84 | Sell |
20-day SMA: | 105.84 | Sell |
50-day SMA: | 108.65 | Sell |
200-day SMA: | 126.03 | Sell |
8-day EMA: | 99.1 | Sell |
20-day EMA: | 103.93 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.8 | Sell |
ProShares UltraPro Short MidCap400 Earnings Growth & SMDD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
ProShares UltraPro Short MidCap400 Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |